| Gregg W Calderwood, MD | |
|
1223 S Gear Ave, Ste 208, West Burlington, IA 52655-1682 | |
| (319) 752-4541 | |
| (319) 752-2972 |
| Full Name | Gregg W Calderwood |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 45 Years |
| Location | 1223 S Gear Ave, West Burlington, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730140898 | NPI | - | NPPES |
| 1730140898 | Other | IA | WELLMARK |
| 1730140898 | Medicaid | IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 22096 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Great River Medical Center | West burlington, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southeast Iowa Regional Medical Center Inc | 3870496417 | 189 |
News Archive
A molecular compound developed by Saint Louis University scientists restored learning, memory and appropriate behavior in a mouse model of Alzheimer's disease, according to findings in the May issue of the Journal of Alzheimer's Disease.
New research from Queen Mary University of London reveals women over the age of 50 who don't attend cervical screening are four times more likely to be diagnosed with cervical cancer in later life.
BioMimetic Therapeutics, Inc. today reported its corporate highlights and financial results as of and for the three and nine months ended September 30, 2012. For the three months ended September 30, 2012, the Company reported a net loss of $4.6 million, or $0.16 per diluted share, compared to a net loss of $7.1 million, or $0.25 per diluted share, for the same period in 2011.
arGEN-X announces that the dose-escalation part of a Phase Ib study with its lead antibody ARGX-110 has met its translational development goals: all pre-specified biological activity measures (e.g. target engagement, effector functions, immune-modulation) were met.
› Verified 2 days ago
| Entity Name | Southeast Iowa Regional Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164433884 PECOS PAC ID: 3870496417 Enrollment ID: O20040130000139 |
News Archive
A molecular compound developed by Saint Louis University scientists restored learning, memory and appropriate behavior in a mouse model of Alzheimer's disease, according to findings in the May issue of the Journal of Alzheimer's Disease.
New research from Queen Mary University of London reveals women over the age of 50 who don't attend cervical screening are four times more likely to be diagnosed with cervical cancer in later life.
BioMimetic Therapeutics, Inc. today reported its corporate highlights and financial results as of and for the three and nine months ended September 30, 2012. For the three months ended September 30, 2012, the Company reported a net loss of $4.6 million, or $0.16 per diluted share, compared to a net loss of $7.1 million, or $0.25 per diluted share, for the same period in 2011.
arGEN-X announces that the dose-escalation part of a Phase Ib study with its lead antibody ARGX-110 has met its translational development goals: all pre-specified biological activity measures (e.g. target engagement, effector functions, immune-modulation) were met.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gregg W Calderwood, MD 1223 S Gear Ave, Ste 208, West Burlington, IA 52655-1682 Ph: (319) 752-4541 | Gregg W Calderwood, MD 1223 S Gear Ave, Ste 208, West Burlington, IA 52655-1682 Ph: (319) 752-4541 |
News Archive
A molecular compound developed by Saint Louis University scientists restored learning, memory and appropriate behavior in a mouse model of Alzheimer's disease, according to findings in the May issue of the Journal of Alzheimer's Disease.
New research from Queen Mary University of London reveals women over the age of 50 who don't attend cervical screening are four times more likely to be diagnosed with cervical cancer in later life.
BioMimetic Therapeutics, Inc. today reported its corporate highlights and financial results as of and for the three and nine months ended September 30, 2012. For the three months ended September 30, 2012, the Company reported a net loss of $4.6 million, or $0.16 per diluted share, compared to a net loss of $7.1 million, or $0.25 per diluted share, for the same period in 2011.
arGEN-X announces that the dose-escalation part of a Phase Ib study with its lead antibody ARGX-110 has met its translational development goals: all pre-specified biological activity measures (e.g. target engagement, effector functions, immune-modulation) were met.
› Verified 2 days ago
Michael J Mccoy, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1223 S Gear Ave, Ste 208, West Burlington, IA 52655 Phone: 319-752-4541 Fax: 319-752-2972 | |
Erin Margaret Haeger, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1223 S Gear Ave, Ste 208, West Burlington, IA 52655 Phone: 319-768-2750 Fax: 319-768-2755 | |
Kimberly A Marshall, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1223 S Gear Ave, Ste 208, West Burlington, IA 52655 Phone: 319-752-4541 Fax: 319-752-2972 | |
Carl H Hays, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1223 S Gear Ave, Ste 208, West Burlington, IA 52655 Phone: 319-752-4541 Fax: 319-752-2972 | |
Dr. Moran Maurine S. Shmulewich Shalev, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1223 S Gear Ave Ste 52655, West Burlington, IA 52655 Phone: 319-768-2755 Fax: 319-768-2755 |